Advertisement


Flora E. van Leeuwen, PhD, on Hodgkin Lymphoma Treatment: Toxicities in Female Survivors

2018 Cancer Survivorship Symposium: Advancing Care and Research

Advertisement

Flora E. van Leeuwen, PhD, of the Netherlands Cancer Institute, discusses cardiovascular disease risk after treatment-induced primary ovarian insufficiency in female survivors of Hodgkin lymphoma (Abstract 114).



Related Videos

Survivorship

Patricia A. Ganz, MD, on Progress in Cancer Survivorship Care

Patricia A. Ganz, MD, of the University of California, Los Angeles, and this year’s recipient of the Ellen Stovall Award for Advancement of Cancer Survivorship Care, discusses her ...

Breast Cancer
Survivorship

Electra D. Paskett, PhD, on Breast Cancer and Arm Mobility: Clinical Trial Results

Electra D. Paskett, PhD, of The Ohio State University Comprehensive Cancer Center, discusses study findings on whether exercise helps women with breast cancer regain arm mobility a...

Survivorship

Genevieve Chaput, MD, on Teaching Primary Care Providers About Survivorship

Genevieve Chaput, MD, of McGill University Health Centre, discusses an accredited workshop that increased primary care providers’ confidence and knowledge about cancer survivorship...

Survivorship

Paul B. Jacobsen, PhD, on The Impact of Survivorship Care Plans: Expert Perspective

Paul B. Jacobsen, PhD, of the National Cancer Institute, discusses his evaluation of whether survivorship care plans have a positive impact on health outcomes and health-care deliv...

Survivorship

Carrie R. Howell, PhD, on Reducing Risks for Childhood Cancer Survivors: Trial Results

Carrie R. Howell, PhD, of St. Jude Children’s Research Hospital, discusses study findings on a web-based exercise intervention for adolescent survivors, who are at increased risk f...

Advertisement

Advertisement



;
Advertisement